November - 2012
| Previous Next | Showing Journal 3 of 23 |
Association of Warfarin Therapy Duration After Bioprosthetic Aortic Valve Replacement With Risk of Mortality, Thromboembolic Complications, and BleedingCharlotte Me ?rie, Lars Køber, Peter Skov Olsen, et al. JAMA, 2012, 308(20):2118-2125 This page is only available to Crit-IQ subscribers. To view the rest of this review and gain access to our vast array of critical care teaching tools including podcasts, vodcasts, modules, exam preparation tools, teaching aids and much more, login here, or Become a Member to register |
November |
Previous Comments
No Comments yet.
Comment
This Danish observational study examines the outcomes in patients with tissue AVR and warfarin therapy (exclude those receiving warfarin prior to surgery or with AF). In 4075 patients there was a median follow-up of 6.57 years. Of these, 187 received aspirin only, 2278 warfarin only, 916...